Learn more about how Amgen oncology is advancing All Angles of Care for cancer patients.
Watch this video on Measurable Residual Disease (MRD).
Learn all about the MOA of blinatumomab in this video.
Explore our Tower Congress video highlighting important data.
See the CANDOR study (DKd vs Kd) data and learn about the DKd regimen.
Learn more about the CANDOR study (DKd vs Kd).
Learn about the mechanism of action and the potential promise of the BiTE® immuno-oncology platform.
Description TK
Explore the difference between generics and biosimilars, along with the biosimilar development pathway, in the first episode of this two-part podcast.
How are biosimilar clinical trials designed to confirm biosimilarity? Find out in the second episode of this two-part podcast.
